United States: Patent

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

Intellectual Property Report

As discussed in our previous article, Comcast sought mandamus relief after Judge Gilstrap of the Eastern District of Texas denied the company's motion to dismiss or transfer for improper venue.

United States IP

BB

Baker Botts LLP

Is The UPC Opening The Door To Prosecution History Estoppel?

[L]ife is too short" to consult the prosecution history when dealing with issues of claim interpretation.

United States IP

JA

J A Kemp LLP

Protecting AI Assets And Outputs With IP Strategies In A Changing World (Podcast)

In this episode of Tech Talks, Julian Dibbell is joined by partner Brian Nolan and associate Megan Fitzgerald to unpack how companies can protect AI assets and outputs using IP strategies.

United States IP

MB

Mayer Brown

D. Mass Patent Litigation Update: November 2025

In Ocean Semiconductors LLC v. Analog Devices Inc., No. 24-cv-11759-PBS, Magistrate Judge Levenson issued two orders addressing discovery disputes brought by Plaintiff.

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

How STEM Students Can Build Dynamic Careers In Intellectual Property

United States IP

MG

Marshall, Gerstein & Borun LLP

To Expedite Or Not To Expedite—That Is The Question. Patent Strategies In The Face Of USPTO Examination Backlogs

United States IP

WD

Wiggin & Dana

Spotlight On Upcoming Oral Arguments – January 2026

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Fast Pass Through The Employer's Legal Landscape: Lap 1

United States Employment

Wa

Ward and Smith, P.A.

AI Patent Outlook For 2026

United States IP

GT

Greenberg Traurig, LLP

2025 IP Update And Year In Review: Navigating Right To Repair And What It Means For Brands In A Changing Aftermarket

United States IP

D

Dykema

Federal Circuit PTAB Appeal Statistics For September-November 2025

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

IP Strategy For Businesses: 5 Key Steps To Protect, Grow & Maximize Your Intellectual Property

United States IP

K

Klemchuk

A New Era In Subject Matter Eligibility At The USPTO?

United States IP

SH

Stites & Harbison PLLC

Radius Health, Inc., f/k/a Nuvios, Inc. v. Orbicular Pharmaceutical Technologies Private Limited et al. (D. Mass. 24-cv-11770).

United States IP

LA

Lando & Anastasi

Italy's Rising Tax Evasion Vs The United States' Is Higher, Even With The Voluntary Disclosure Program (VDP)

United States Tax

RS

Rotfleisch & Samulovitch P.C.

USPTO Proposes Dramatic Restrictions For Inter Partes Review Institution

United States IP

OB

Osha Bergman Watanabe & Burton LLP

Supreme Court Weighs Extent Of President's Authority To Impose Tariffs During Proclaimed National Emergencies

United States Litigation

D

Dykema

What Honeybees Have Taught Me About Dispute Resolution

United States Litigation

J

JAMS

Food Venture Financing News – Weekly Issue No. 265

United States Healthcare

DW

Davis Wright Tremaine

More Than Math: How Desjardins Recognizes AI Innovations As Patent-Eligible Technology

On November 4, 2025, the USPTO in Ex parte Desjardins designated as precedential an earlier Appeals Review Panel (ARP) decision overruling the Patent Trial and Appeal Board (Board).

United States IP

CM

Crowell & Moring LLP

Everything Old Is New Again At The USPTO

Over the years, the United States Patent and Trademark Office (USPTO) has instituted policies and procedures to help manage the workflow of the agency.

United States IP

FB

FBT Gibbons

PTAB Voluntary Search Disclosure Declarations: A New Factor Supporting Institution

Effective immediately, a bona fide SDD will be treated as a non‑exclusive, non‑dispositive favorable factor at institution, with no adverse inference for parties who do not participate.

United States IP

JD

Jones Day

FDA Approves MAbxience And Amneal's Denosumab Biosimilars

On December 22, 2025, the FDAapprovedmAbxience and Amneal's Biologics Licensing Applications (BLAs) for BONCRESA (denosumab-mobz) and OZILTUS (denosumab-mobz)...

United States IP

GP

Goodwin Procter LLP

UPC Aligns With The EPO In Allowing Functional Antibody Claims

United States IP

JD

Jones Day

PTAB Year In Review: A Tumultuous 2025

United States IP

II

Irwin IP

EP And Council Of The EU Reach Provisional Agreement On New Genomic Techniques For Plants

United States IP

BC

Bergeson & Campbell

A Perpetual Motion Holiday Special – Wacky Patents (Podcast)

United States IP

PC

Perkins Coie LLP

Priority Through Assignment: Federal Circuit Validates Mid-Opposition Acquisition Of Common Law Trademark Rights

United States IP

II

Irwin IP

IP Mediation Saves Litigation Costs

United States IP

K

Klemchuk

Regeneron Seeks To Bifurcate Or Stay Amgen's Antitrust Claims In Aflibercept Patent Litigation

United States IP

GP

Goodwin Procter LLP

Global Patent Litigation: Strategic Insights Across U.S., Germany, And China

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Federal Circuit "Corrects" Antecedent Basis, Reversing District Court's Indefiniteness Ruling

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

IPR And PGR Statistics For Final Written Decisions Issued In September And October 2025

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Regeneron Seeks To Bifurcate Or Stay Amgen's Antitrust Claims In Aflibercept Patent Litigation

On December 11, 2025, Regeneron filed a Memorandum in Support of Its Motion to Bifurcate and Stay Amgen's Antitrust Claims in the ongoing aflibercept...

United States IP

GP

Goodwin Procter LLP

Global Patent Litigation: Strategic Insights Across U.S., Germany, And China

The same four questions govern every patent case, but the answers vary radically by forum: Remedies, timing, cost, and likelihood of success are universal considerations...

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Federal Circuit "Corrects" Antecedent Basis, Reversing District Court's Indefiniteness Ruling

In Canatex Completion Sols., Inc. v. Wellmatics, LLC, No. 2024-1466 (Fed. Cir. Nov. 12, 2025), the Federal Circuit reversed and remanded a district court decision finding Canatex's asserted claims invalid for indefiniteness.

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

IPR And PGR Statistics For Final Written Decisions Issued In September And October 2025

In September and October, the PTAB cancelled 1,143 (79.82%) instituted claims across 70 IPR and PGR Final Written Decisions, including decisions issued following remand...

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

The Patents Behind Holiday Traditions

United States IP

LD

Lerner David

Federal Circuit Clarifies That Only Identical Inventors Avoid Becoming Prior Art Under Pre-AIA 102(e)

In Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., No. 25-1210 (Fed. Cir. Oct. 30, 2025), the Federal Circuit affirmed a PTAB decision invalidating...

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Artificial Intelligence And Intellectual Property: Challenges, Litigation, And Future Directions

The article discusses emerging issues in patent, trade secret, trademark, and copyright litigation involving AI technology

United States Technology

N

NERA

Federal Circuit Patent Watch: Disclosure Of A Broad Genus Is Insufficient Written Description Support For A Subgenus Of Chemical Structures Without Adequate Blaze Marks

Moore, J. The Court reversed the district court's judgment of infringement of the asserted '043 patent under the doctrine of equivalents ("DOE"), rejected a pair of claim construction arguments for the asserted '043 patent.

United States IP

W

WilmerHale

"Engineering Meets Science: A Conversation With Matt Jorge" (Podcast)

Marshall Gerstein Partner Matt Jorge recently joined The Litigator's Edge podcast for a conversation focused on protecting innovation at the intersection of engineering, science, and intellectual property law.

United States IP

MG

Marshall, Gerstein & Borun LLP

IPR Estoppel Under § 315(e)(1) Does Not Apply To Ongoing Ex Parte Reexamination

United States IP

AG

Akin Gump Strauss Hauer & Feld LLP

The UPC Warms To Its Long-arm Jurisdiction Powers As BSH Takes Effect Across European Patent Courts

European Union IP

KL

Herbert Smith Freehills Kramer LLP

2025 Patent Eligibility Guidance For Subject Matter Eligibility Declarations (SMEDs)

United States IP

L

Losey

A New Era For AI Patents: USPTO Shifts Stance On Eligibility And Evidence

United States IP

LD

Lerner David

The UPC's Approach To Inventive Step

United States IP

AO

A&O Shearman

Ineffective Retroactive Amendment Of Patent Assignment Dooms $20 Million Damages Verdict

United States IP

AG

Akin Gump Strauss Hauer & Feld LLP

"The STEM Side Of Patent Law: Inside IP With Christine Hollis" (Podcast)

United States IP

MG

Marshall, Gerstein & Borun LLP

Guidance On Rule 132 Declarations For Patent Eligibility

United States IP

FH

Foley Hoag LLP

2025 Patent Prosecution Year In Review: Key Developments, Case Law, And Strategic Insights For Patent Attorneys (Video)

United States IP

BK

Brooks Kushman

Samsung Advances In Alter Ego Discovery For Jurisdiction: Court Orders Production And Depositions In CM HK Dispute Where Affiliates Used Common Servers

United States IP

JM

Jeffer Mangels Butler & Mitchell LLP

Navigating Bayh-Dole Compliance In 2025: Risks And Risk Mitigation Strategies

United States IP

FH

Foley Hoag LLP

Bayh-Dole Compliance Requires Your Attention: Best Practices For Universities, Companies, Investors, Strategic Partners, And Acquirors

United States Healthcare

FH

Foley Hoag LLP

Podcast: Mike Jakes Reflects On His 37-Year Career In IP

United States IP

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

The Progressively Well-Established Basis For AI Subject Matter Eligibility At The USPTO

United States IP

C

Caldwell

USPTO Fee Changes To Take Effect In January 2025: What You Need To Know

United States IP

HM

Honigman

See more

Highlighted Content

Parallel Imports, A Global Phenomenon, And A Very Grey Area Regarding International Trade

United States International

BG

Braumiller Law Group, PLLC

Knowing What's Ahead: Dispute Resolution Planning For Startups In The New Age Of Generative AI

United States Litigation

J

JAMS

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Latest Videos

See more

2025 Patent Prosecution Year In Review: Key Developments, Case Law, And Strategic Insights For Patent Attorneys (Video)

BK

Brooks Kushman

Why Your Tech Business Needs Employee Agreements (IP & Confidentiality) (Video)

C

Crowley Law LLC

Tips For Small Brands To Consider When Protecting Their Intellectual Property (Video)

WL

Withers LLP

Parameters At The EPO (Video)

JA

J A Kemp LLP

How To Navigate IP Issues In Robotics (Video)

FH

Foley Hoag LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More